SPBC1271.08c Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Characteristics and Target

  • Target Gene: SPBC1271.08c encodes a predicted membrane transporter in S. pombe. Its function aligns with uncharacterized MFS-type (Major Facilitator Superfamily) transporters .

  • Antibody Type: Likely a rabbit polyclonal antibody, given the prevalence of rabbit-derived polyclonal antibodies in yeast protein studies .

  • Applications: Likely validated for Western blot (WB) and ELISA, as seen with similar SPBC1271 antibodies .

SPBC1271.05c Antibody

  • Function: Targets a zinc finger protein involved in cell wall remodeling and septum assembly .

  • Applications: Used in Western blot and immunoprecipitation to study cell cycle regulation .

  • Key Insight: Antibodies targeting SPBC1271 family proteins are critical for elucidating yeast cell wall dynamics .

SPBC1271.10c Antibody

  • Function: Targets a predicted membrane transporter with homology to drug efflux pumps .

  • Applications: Validated for Western blot to study protein localization and expression .

Potential Applications for SPBC1271.08c Antibody

ApplicationRationale
Western BlotTo confirm protein expression and localization in S. pombe lysates .
ELISAFor quantitative analysis of SPBC1271.08c in cell lysates or purified fractions .
Co-IP/MSTo identify interacting proteins and pathway components .
Cell BiologyTo study membrane trafficking or transporter activity in fission yeast .

Technical Considerations

  • Antibody Validation: Western blot validation requires orthogonal methods (e.g., mass spectrometry) to confirm specificity .

  • Cross-Reactivity: Potential off-target binding to homologous SPBC1271 family proteins must be ruled out .

Research Context

Fission yeast (S. pombe) is a model organism for studying eukaryotic cell biology. SPBC1271.08c’s role in membrane transport aligns with broader studies on cellular trafficking and stress responses . Antibodies like SPBC1271.08c enable functional characterization of unannotated genes, a critical gap in yeast genomics .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPBC1271.08c; Uncharacterized protein C1271.08c
Target Names
SPBC1271.08c
Uniprot No.

Target Background

Database Links
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is SPBC1271.08c and why are antibodies against it important for research?

SPBC1271.08c is an uncharacterized protein from Schizosaccharomyces pombe (fission yeast), cataloged in genomic databases as a protein-coding gene . Antibodies against this protein are valuable research tools for studying S. pombe cellular processes, protein localization, and functional characterization. Despite being labeled as "uncharacterized," antibodies targeting this protein allow researchers to investigate its expression patterns, subcellular localization, and potential interactions with other cellular components.

According to available resources, SPBC1271.08c protein has been classified within the zinc finger protein family, specifically as an AN1-type zinc finger protein . This classification suggests potential roles in transcriptional regulation, protein-protein interactions, or stress responses, making antibodies against this protein particularly valuable for studying these cellular processes in fission yeast models.

What are the key specifications of commercially available SPBC1271.08c antibodies?

Commercial SPBC1271.08c antibodies are primarily available as polyclonal antibodies raised in rabbits, with specificity for Schizosaccharomyces pombe strain 972/24843 (fission yeast) . These antibodies typically have the following specifications:

CharacteristicSpecification
HostRabbit
ReactivitySchizosaccharomyces pombe (strain 972/24843)
IsotypeIgG
Purification MethodAntigen-affinity
ApplicationsELISA (EIA), Western Blot (WB)
FormatPurified IgG - liquid
Recommended Storage-20°C (avoid repeated freeze-thaw cycles)

The antibodies are typically purified using antigen-affinity chromatography to enhance specificity and reduce background . This is particularly important when working with relatively uncharacterized proteins where cross-reactivity could confound experimental results.

What is the optimal Western blotting protocol for SPBC1271.08c antibody?

The optimal Western blotting protocol for SPBC1271.08c antibody follows standard procedures with specific optimizations for this particular antibody:

  • Sample Preparation:

    • Lyse S. pombe cells in RIPA buffer containing protease inhibitors at 4°C

    • Maintain constant agitation for 30 minutes

    • Centrifuge at 16,000 × g for 20 minutes at 4°C

    • Collect supernatant and determine protein concentration

  • Gel Electrophoresis and Transfer:

    • Load 20-50 μg of total protein per well

    • Separate proteins using 10-12% SDS-PAGE

    • Transfer to 0.2 μm nitrocellulose or PVDF membrane

  • Blocking and Antibody Incubation:

    • Block membrane in 3-5% BSA in TBST for 1 hour at room temperature

    • Incubate with SPBC1271.08c primary antibody (1:500-1:1000 dilution) overnight at 4°C

    • Wash three times with TBST for 5 minutes each

    • Incubate with HRP-conjugated secondary antibody (1:2000-1:5000) for 1 hour at room temperature

    • Wash three times with TBST for 5 minutes each

  • Detection:

    • Apply chemiluminescent substrate to membrane

    • Capture signals using a CCD camera-based imager

    • Analyze band intensity with appropriate image analysis software

For enhanced detection of low-abundance SPBC1271.08c protein, consider using a Western blot enhancer system which can increase signal intensity and reduce background .

How should S. pombe samples be prepared for optimal detection of SPBC1271.08c?

For optimal detection of SPBC1271.08c in S. pombe samples, follow these methodological guidelines:

  • Cell Culture Preparation:

    • Grow S. pombe cells to mid-log phase (OD600 = 0.5-0.8) in appropriate media

    • Harvest cells by centrifugation at 1,000 × g for 5 minutes

    • Wash cell pellet with ice-cold PBS or TBS

  • Cell Lysis Methods:

    • Method A (Chemical Lysis):

      • Resuspend cells in RIPA buffer (1 ml per 10^8 cells) containing protease inhibitors

      • Incubate on ice for 30 minutes with gentle mixing

      • Centrifuge at 16,000 × g for 20 minutes at 4°C

      • Collect supernatant

    • Method B (Mechanical Disruption):

      • Resuspend cells in lysis buffer

      • Disrupt cells using glass beads in a bead beater (8 cycles of 30 seconds on/30 seconds off)

      • Centrifuge at 16,000 × g for 20 minutes at 4°C

      • Collect supernatant

  • Protein Preservation Considerations:

    • Add protease inhibitor cocktail to prevent degradation

    • For phosphorylated protein variants, include phosphatase inhibitors

    • Process samples quickly and maintain at 4°C throughout

    • Aliquot samples and store at -80°C to avoid freeze-thaw cycles

The choice between chemical and mechanical lysis depends on the subcellular localization of SPBC1271.08c. If the protein is tightly associated with cellular structures, mechanical disruption may provide better extraction efficiency.

How can I validate the specificity of SPBC1271.08c antibody in my experiments?

Validating SPBC1271.08c antibody specificity is crucial for ensuring reliable experimental results. Implement these validation strategies:

  • Genetic Controls:

    • Compare wild-type S. pombe with SPBC1271.08c deletion mutants

    • Use SPBC1271.08c overexpression strains as positive controls

    • If working with tagged versions, compare with untagged control strains

  • Biochemical Validation:

    • Peptide Competition Assay:

      • Pre-incubate antibody with excess purified SPBC1271.08c protein or immunizing peptide

      • Run parallel Western blots with blocked and unblocked antibody

      • Specific bands should disappear in the blocked antibody lane

    • Immunodepletion Test:

      • Incubate antibody with recombinant SPBC1271.08c protein immobilized on beads

      • Use unbound fraction as a negative control in parallel with regular antibody

      • Compare detection patterns as demonstrated with other proteins like Rhb1

  • Mass Spectrometry Confirmation:

    • Immunoprecipitate using SPBC1271.08c antibody

    • Excise bands of interest from SDS-PAGE

    • Perform mass spectrometry analysis to confirm protein identity

When validating antibody specificity, it's essential to consider potential cross-reactivity with structurally similar proteins, particularly other zinc finger family members that may share domain similarities with SPBC1271.08c.

What approaches can be used to study SPBC1271.08c protein interactions and function?

Given the uncharacterized nature of SPBC1271.08c, multiple complementary approaches should be employed:

  • Co-Immunoprecipitation (Co-IP):

    • Lyse S. pombe cells under gentle conditions (non-denaturing buffer)

    • Incubate cell lysate with SPBC1271.08c antibody bound to protein A/G beads

    • Wash extensively to remove non-specific interactions

    • Elute bound proteins and analyze by mass spectrometry to identify interacting partners

  • Chromatin Immunoprecipitation (ChIP):

    • If SPBC1271.08c functions as a transcriptional regulator (suggested by zinc finger domain)

    • Cross-link S. pombe cells with formaldehyde

    • Perform immunoprecipitation with SPBC1271.08c antibody

    • Analyze bound DNA by sequencing to identify genomic binding sites

  • Localization Studies:

    • Use SPBC1271.08c antibody for immunofluorescence microscopy

    • Compare with GFP-tagged versions of the protein

    • Examine co-localization with known cellular markers

    • Analyze changes in localization under different stress conditions

  • Functional Genomics Analysis:

    • Integrate antibody-based experimental data with transcriptomics

    • Compare phenotypes of deletion mutants with wild-type strains

    • Examine genetic interactions through synthetic genetic array analysis

    • Use antibodies to monitor protein levels in different genetic backgrounds

The combination of these approaches can provide insights into the biological function of SPBC1271.08c, despite its current uncharacterized status.

What are common issues when using SPBC1271.08c antibody in Western blotting and how can they be resolved?

Researchers frequently encounter these challenges when working with SPBC1271.08c antibody:

IssuePossible CausesSolutions
Weak or no signal- Low abundance of SPBC1271.08c
- Inefficient protein transfer
- Suboptimal antibody concentration
- Increase sample loading (50-100 μg)
- Optimize transfer conditions for high MW proteins
- Increase antibody concentration
- Use Western blot enhancer
High background- Insufficient blocking
- Excessive secondary antibody
- Non-specific binding
- Extend blocking time to 2 hours
- Reduce secondary antibody concentration
- Use 5% BSA instead of milk for blocking
- Increase wash duration and frequency
Multiple bands- Protein degradation
- Post-translational modifications
- Cross-reactivity
- Add fresh protease inhibitors
- Maintain samples at 4°C during preparation
- Perform peptide competition assay to identify specific bands
Inconsistent results- Variability in sample preparation
- Protein modification differences
- Antibody lot variation
- Standardize lysate preparation protocol
- Create internal loading controls
- Validate each new antibody lot

If experiencing persistent issues with background in Western blots using SPBC1271.08c antibody, consider implementing a specialized enhancer protocol:

  • After protein transfer, wash membrane with ultrapure water

  • Apply antigen pretreatment solution for 10 minutes

  • Rinse thoroughly with ultrapure water before blocking

  • Dilute primary antibody in specialized antibody diluent

  • Continue with standard Western blot protocol

How can I optimize immunoprecipitation experiments using SPBC1271.08c antibody?

For successful immunoprecipitation of SPBC1271.08c and its interacting partners:

  • Buffer Optimization:

    • Test multiple lysis buffers with varying stringency:

      • Low stringency: 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate

      • Medium stringency: RIPA buffer

      • High stringency: Add 0.1% SDS to RIPA buffer

    • The optimal buffer depends on the strength of protein interactions being studied

  • Antibody Coupling Strategy:

    • Direct coupling method:

      • Covalently link SPBC1271.08c antibody to activated beads

      • Advantages: No antibody contamination in eluted samples

      • Disadvantages: Possible reduction in antibody activity

    • Indirect method:

      • Use protein A/G beads to capture antibody-antigen complexes

      • Advantages: Preserves antibody activity

      • Disadvantages: Antibody contamination in eluate

  • Experimental Controls:

    • Perform parallel IP with non-specific IgG from same species

    • Include SPBC1271.08c deletion strain as negative control

    • Pre-clear lysates with beads alone before adding antibody

    • Incorporate input, flow-through, and IP samples in analysis

  • Cross-linking Considerations:

    • For transient interactions, use formaldehyde (1%) or DSP cross-linker

    • For stable complexes, cross-linking may be unnecessary

    • Optimize cross-linking time to balance capture efficiency with specificity

The choice of method should be guided by the specific research question and the suspected nature of SPBC1271.08c interactions.

How does post-translational modification affect detection of SPBC1271.08c with antibodies?

SPBC1271.08c may undergo various post-translational modifications (PTMs) that can significantly impact antibody recognition:

  • Potential Modifications in Zinc Finger Proteins:

    • Farnesylation: Based on studies of similar proteins like cpp1 in S. pombe, zinc finger proteins can undergo farnesylation, which alters their electrophoretic mobility on SDS-PAGE . This modification may result in detection of multiple bands with varied molecular weights.

    • Phosphorylation: Zinc finger proteins often undergo regulatory phosphorylation. If studying phosphorylated forms of SPBC1271.08c:

      • Include phosphatase inhibitors in lysis buffer

      • Consider phospho-specific antibodies if available

      • Use lambda phosphatase treatment as a control

    • Ubiquitination: AN1-type zinc finger proteins may undergo ubiquitination. To detect ubiquitinated forms:

      • Include deubiquitinase inhibitors in lysis buffer

      • Use denaturing conditions to disrupt ubiquitin-protein interactions

      • Consider larger MW bands as potential ubiquitinated forms

  • Experimental Approaches:

    • Run parallel samples with and without specific PTM inhibitors

    • Incorporate enzymatic treatments (phosphatases, deubiquitinases)

    • Perform 2D gel electrophoresis to separate modified forms

    • Consider immunoprecipitation followed by PTM-specific antibody detection

Understanding the pattern of SPBC1271.08c modifications can provide insights into its regulation and function in different cellular contexts.

What are the considerations for cross-species applications of SPBC1271.08c antibodies?

While SPBC1271.08c antibodies are designed for S. pombe specificity, researchers sometimes explore cross-species applications:

  • Sequence Homology Analysis:

    • Before attempting cross-species application, perform sequence alignment of SPBC1271.08c with potential homologs

    • Focus on the epitope region recognized by the antibody

    • Minimum recommended homology: >70% identical amino acids in epitope region

  • Validation in Non-Target Species:

    • Always include positive control (S. pombe lysate)

    • Perform Western blot with increasing protein amounts from target species

    • Include knockout/knockdown controls when available

    • Consider synthesized peptide competition assays with both S. pombe and target species peptides

  • Species-Specific Considerations:

    • For applications in S. cerevisiae, identify the closest homolog and examine domain conservation

    • For mammalian applications, expect significantly lower cross-reactivity due to evolutionary distance

    • Consider raising custom antibodies against conserved epitopes for multi-species studies

Cross-species antibody applications require extensive validation and should always be interpreted with caution, particularly for relatively uncharacterized proteins like SPBC1271.08c.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.